CIK 0002030763 · <br>Emerging growth company
DataMeds AI, Inc.
Sign in to watch- Ticker
- MEDS
- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 933264234
- Phone
- 1-843-302-1785
- Business address
- 3000 BAYPORT DRIVE SUITE 950, TAMPA, FL, 33607
- Former names
- Wellgistics Health, Inc., Danam Health, Inc
- 8-K Event Material agreement · Executive or director change
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Regulation FD disclosure
- DRS Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure
- 8-K Event Unregistered share sale · Regulation FD disclosure
- 10-K Report Annual Report
- 4 Grant or award Chief Clinical Officer acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Grant or award Director acquired 4,082,247 shares (grant or award)
- 4 Grant or award Chief Strategy Officer acquired 4,082,247 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 9,000,000 shares (grant or award)
- 4 Grant or award Chief Pharmacy Officer acquired 90,000 shares (grant or award)
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 7 of 9 · 179 filings